Publication | Open Access

High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia

Psychoactive DrugAttention ControlPsychiatryPsychotic DisorderPsychopharmacologySchizophreniaNeuropharmacologyInhibitory ControlSocial SciencesNeuroscienceAttentionMemory PerformanceMedicinePsychopathology